Implementation of peripheral blood CD34 analyses to initiate leukapheresis: marked reduction in resource utilization
- 27 February 2006
- journal article
- Published by Wiley in Transfusion
- Vol. 46 (4) , 523-529
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and costBone Marrow Transplantation, 2004
- Resveratrol blocks interleukin-1β–induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cellsBlood, 2003
- Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's LymphomaBone Marrow Transplantation, 2003
- Cost-effectiveness of CD34+ dose in peripheral blood progenitor cell transplantation for non-Hodgkin’s lymphoma patients: a single centre studyBone Marrow Transplantation, 2000
- Characterization and Outcome of “Hard to Mobilize” Lymphoma Patients Undergoing Autologous Stem Cell TransplantationLeukemia & Lymphoma, 2000
- Economic considerations in the use of peripheral blood progenitor cells to support high-dose chemotherapyBone Marrow Transplantation, 1999
- Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell contentBone Marrow Transplantation, 1997
- Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantationBone Marrow Transplantation, 1997
- Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate dose cyclophosphamide and G-CSFLeukemia Research, 1997
- Autologous Transplantation of Blood Stern Cells Mobilized with Filgrastim Alone in 93 Patients with Malignancies: The Number of CD34+ Cells Reinfused Is the Only Factor Predicting Both Granulocyte and Platelet RecoveryJournal of Hematotherapy, 1996